Maham Fatima
Sun, May 17, 2026 astatine 11:15 PM CDT 2 min read
Operating expenses roseate owed to commercialized infrastructure enlargement and marketing, resulting successful a GAAP nett nonaccomplishment of $112.1 cardinal ($0.85 per share) and a non-GAAP nett nonaccomplishment of $58.7 cardinal ($0.45 per share). The adjusted EBITDA nonaccomplishment was $58.9 million, portion escaped currency travel stood astatine antagonistic $71.2 million. Guardant Health Inc. (NASDAQ:GH) closed the 4th with $1.2 cardinal successful cash, currency equivalents, restricted cash, and marketable securities.
Key operational milestones included expanding Guardant360 Tissue capabilities, securing FDA companion diagnostic support for Guardant360 CDx, and partnering with Quest and Manulife. Driven by this momentum, the institution raised its full-year 2026 gross guidance to a scope of $1.30 to $1.32 billion, representing 32% to 34% maturation implicit the anterior year.
Guardant Health Inc. (NASDAQ:GH) is simply a precision oncology firm.
While we admit the imaginable of GH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey connected Google News.

2 days ago
3





English (CA) ·
English (US) ·
Spanish (MX) ·